ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,827Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 64

$725K Total Retail Price of All Prescriptions

Rank: 4 out of 64

1,704 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,494 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
METOPROLOL TARTRATE 1,584 1,263 1 1
CLOPIDOGREL 998 728 2 4
AMLODIPINE BESYLATE 890 705 3 5
SIMVASTATIN 882 702 4 3
PLAVIX 761 543 5 9
WARFARIN SODIUM 634 505 6 11
LISINOPRIL 625 478 7 7
FUROSEMIDE 536 390 8 6
ATORVASTATIN CALCIUM 532 369 9 8
BENAZEPRIL HCL 411 309 10 25
CARVEDILOL 316 224 11 2
CHLORTHALIDONE 275 187 12 36
HYDROCHLOROTHIAZIDE 247 213 13 22
ATENOLOL 242 174 14 15
DIGOXIN 222 187 15 18
AMIODARONE HCL 210 175 16 28
CRESTOR 200 157 17 12
METOPROLOL SUCCINATE 197 169 18 10
PRADAXA 193 178 19 26
LIPITOR 177 132 20 31
BENAZEPRIL-HYDROCHLOROTHIAZIDE 170 138 21 59
CLONIDINE HCL 167 121 22 39
HYDRALAZINE HCL 154 114 23 32
NITROGLYCERIN PATCH 146 114 24 29
NITROSTAT 139 89 25 21
SPIRONOLACTONE 137 98 26 19
PRAVASTATIN SODIUM 136 105 27 14
POTASSIUM CHLORIDE 121 109 28 17
RAMIPRIL 120 102 29 23
LOSARTAN POTASSIUM 116 84 30 13
SOTALOL 113 113 31 27
BUMETANIDE 101 90 32 46
ISOSORBIDE MONONITRATE ER 98 73 33 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 82 34 61
BYSTOLIC 94 80 35 30
DIOVAN HCT 89 73 36 60
RANEXA 89 62 36 24
EFFIENT 84 61 38 20
OMEPRAZOLE 82 74 39 56
PROPAFENONE HCL 80 75 40 69
DIOVAN 76 52 41 34
FLECAINIDE ACETATE 69 60 42 65
TRILIPIX 68 56 43 64
LEVOTHYROXINE SODIUM 68 57 43 58
LOSARTAN-HYDROCHLOROTHIAZIDE 67 62 45 41
DILTIAZEM 24HR ER 67 58 45 48
LOVASTATIN 67 59 45 38
FENOFIBRATE 65 48 48 44
DILTIAZEM 24HR CD 58 51 49 37
XARELTO 57 54 50 43
DILTIAZEM HCL 57 50 50 90
NIFEDIPINE ER 53 40 52 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.